Translational Development Acquisition (TDAC) Shares Outstanding (2023 - 2026)
Translational Development Acquisition's (TDAC) quarterly Shares Outstanding (Entity) came in at $17.2 million in Q1 2026, little changed YoY from $17.2 million in Q1 2025, and little changed on a QoQ basis from $17.2 million in Q4 2025.
Translational Development Acquisition (TDAC) Shares Outstanding (2023 - 2026) Analysis & Trends
Translational Development Acquisition (TDAC) has 4 years of Shares Outstanding (Entity) data on file, last reported at $17.2 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) changed 0.0% year-over-year to $17.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.2 million (changed 0.0% YoY) and the FY2025 annual result came in at $17.2 million, up 270.37% from the prior year.
- Shares Outstanding (Entity) was little changed at $17.2 million in Q1 2026, from $17.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $17.2 million in Q1 2025 to a low of $4.7 million in Q4 2023.
- A 4-year average of $12.5 million and a median of $17.2 million in 2025 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) changed 0.0% — and 2025, when it soared 270.37%.
- Tracing TDAC's Shares Outstanding (Entity) over 4 years: stood at $4.7 million in 2023, then changed by 0.0% to $4.7 million in 2024, then soared by 270.37% to $17.2 million in 2025, then changed by 0.0% to $17.2 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $17.2 million (Q1 2026), $17.2 million (Q4 2025), and $17.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 25.30 Mn |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 23.00 Mn |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 50.00 Mn |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 45.00 Mn |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 22.84 Mn |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 23.00 Mn |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 30.00 Mn |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 35.88 Mn |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 32.92 Mn |
| 10 | Translational Development Acquisition | 182.66 Mn | 182.57 Mn | - | 16.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.25 Mn |
| Dec 31, 2025 | 17.25 Mn |
| Sep 30, 2025 | 17.25 Mn |
| Jun 30, 2025 | 17.25 Mn |
| Mar 31, 2025 | 17.25 Mn |
| Dec 31, 2024 | 4.06 Mn |
| Sep 30, 2024 | 4.05 Mn |
| Dec 31, 2023 | 4.05 Mn |